(NYSEMKT: AZTR) Azitra's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.99%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.33%.
Azitra's earnings in 2026 is -$10,955,370.On average, 4 Wall Street analysts forecast AZTR's earnings for 2026 to be -$18,415,660, with the lowest AZTR earnings forecast at -$21,422,595, and the highest AZTR earnings forecast at -$14,961,813. On average, 4 Wall Street analysts forecast AZTR's earnings for 2027 to be -$46,843,104, with the lowest AZTR earnings forecast at -$67,639,052, and the highest AZTR earnings forecast at -$23,972,904.
In 2028, AZTR is forecast to generate -$9,909,772 in earnings, with the lowest earnings forecast at -$9,521,154 and the highest earnings forecast at -$10,201,236.